Sanofi reports findings from Phase II relapsing MS treatment trial

Sanofi reports findings from Phase II relapsing MS treatment trial

Submitted by admin on July 1, 2024 - 11:00am
Source: 
Clinical Trials Arena
News Tags: 
Sanofi
frexalimab
relapsing multiple sclerosis
MS
clinical trials
Headline: 
Sanofi reports findings from Phase II relapsing MS treatment trial
snippet: 

Sanofi has reported the latest data from a Phase II clinical trial of a cluster of differentiation 40 ligand (CD40L) monoclonal antibody, frexalimab, in patients with relapsing multiple sclerosis (MS).

Do Not Allow Advertisers to Use My Personal information